Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion
Sponsors
St. Olavs Hospital HF, CHU Gabriel-Montpied, Centre Hospitalier Regional Universitaire De Tours, Universitair Ziekenhuis Antwerpen
Conditions
Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:Patients in ICU with risks of Acute Respiratory Distress SyndromeRetinopathy of prematuritySedation in healthy children
Phase 2
The use of intranasal dexmedetomidine for pediatric sedation in non-invasive radiological procedures (CTMS 004321)
Assessing the efficacy and safety profile of intranasal dexmedetomidine for procedural sedation in radiological procedures in children with a prospective exploratory interventional monocentric study in a tertiary center in Antwerp (Belgium)
Not yet recruitingCTIS2025-522778-34-00
Target: 100Updated: 2025-11-07
Pain Relief at Screening for Retinopathy of Prematurity - The PROPER study
Not yet recruitingCTIS2023-507975-23-01
Target: 33Updated: 2026-06-22
Phase 3
Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome
RecruitingCTIS2024-517670-15-00
Start: 2023-07-24Target: 80Updated: 2025-11-10
Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: the PEDIADEX randomized controlled trial
Not yet recruitingCTIS2025-521039-35-00
Target: 266Updated: 2025-10-29